Northern Trust Corp Alvotech Transaction History
Northern Trust Corp
- $658 Billion
- Q1 2025
A detailed history of Northern Trust Corp transactions in Alvotech stock. As of the latest transaction made, Northern Trust Corp holds 108,454 shares of ALVO stock, worth $999,945. This represents 0.0% of its overall portfolio holdings.
Number of Shares
108,454
Previous 110,241
1.62%
Holding current value
$999,945
Previous $1.46 Million
27.97%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ALVO
# of Institutions
50Shares Held
15.8MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA4.19MShares$38.7 Million0.0% of portfolio
-
Bracebridge Capital, LLC2.71MShares$24.9 Million20.4% of portfolio
-
Howard Marks Oaktree Capital Management LP | Los Angeles, Ca1.87MShares$17.2 Million0.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD1.4MShares$12.9 Million0.0% of portfolio
-
Littlejohn & CO LLC1.32MShares$12.2 Million6.46% of portfolio
About Alvotech
- Ticker ALVO
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 248,650,000
- Market Cap $2.29B
- Description
- Alvotech, through its subsidiaries, develops and manufactures biosimilar medicines for patients worldwide. It offers biosimilar products in the therapeutic areas of autoimmune, eye, and bone disorders, as well as cancer. The company's lead program is AVT02, a high concentration formulation biosimilar to Humira to treat various inflammatory condi...